ARTICLE | Clinical News
Texas Biotech regulatory update
July 25, 1994 7:00 AM UTC
The Houston company said Immuno-Pharmaceutics Inc. has received U.S. patent No. 5,331,573, covering a supercomputer-based rational drug design technology. TXB is in the process of finalizing a letter of intent to acquire the San Diego company. ...